Shows
The Respiratory Futures PodcastBonus Episode: Live from the BTS Winter MeetingIn this Episode, host Dr Charlie Addy speaks to four incredible guests in person at the Winter Meeting.You will hear a summary of the Winter Meeting with outgoing chair Professor James Chalmers and a look to the future with new President Professor Nick Maskell. We also covered the multi-disciplinary team in science and research with Aleksandra Gawlik-Lipinski and welcomed the new chair of the Science and Research committee Professor Mona Bafadhel who spoke of her plans for next year’s meeting.The views expressed by...2024-12-1237 min
The Dr. Sam Collins Podcast - "Stripped Back"Climbing MountainsSam chats with Mona Bafadhel, the new Chair of Respiratory Medicine, King’s College London about her career, failing and being called "challenging.” 2022-04-0452 min
Listen to The Lancet Respiratory MedicineInhaled budesonide in the treatment of early COVID-19Dr. Mona Bafadhel discusses the STOIC trial, which looked at the use of inhaled budesonide in the treatment of early COVID-19.2021-04-1610 min
The Lancet Respiratory Medicine in conversation withInhaled budesonide in the treatment of early COVID-19Dr. Mona Bafadhel discusses the STOIC trial, which looked at the use of inhaled budesonide in the treatment of early COVID-19.Read the full article:https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(21)00160-0/fulltextContinue this conversation on social!Follow us today at...https://thelancet.bsky.social/https://instagram.com/thelancetgrouphttps://facebook.com/thelancetmedicaljournalhttps://linkedIn.com/company/the-lancethttps://youtube.com/thelancettv2021-04-1510 min
Inside Covid-19Inside Covid-19: Medical breakthroughs - common asthma drug Budesonide, Ivermectin in treating coronavirusIn an important scientific breakthrough in the early treatment of Covid-19, medical experts have discovered that an inhaled corticosteroid is effective. Hear from Professor Mona Bafadhel of the University of Oxford’s Nuffield Department of Medicine about how this medication commonly used to treat asthma appears to significantly reduce the need for urgent care and hospitalisation in people with Covid-19. Ivermectin is being developed into a form that is easily dissolved on the tongue or injected; and hear about an app that can use a person’s voice to detect early symptoms of Covid-19. Dr Davd Liu, CEO of Sonde Heal...2021-02-1131 min
Inside Covid-19Inside Covid-19: Medical breakthroughs - common asthma drug Budesonide, Ivermectin in treating coronavirusIn an important scientific breakthrough in the early treatment of Covid-19, medical experts have discovered that an inhaled corticosteroid is effective. Hear from Professor Mona Bafadhel of the University of Oxford’s Nuffield Department of Medicine about how this medication commonly used to treat asthma appears to significantly reduce the need for urgent care and hospitalisation in people with Covid-19. Ivermectin is being developed into a form that is easily dissolved on the tongue or injected; and hear about an app that can use a person’s voice to detect early symptoms of Covid-19. Dr Davd Liu, CEO of Sonde Heal...2021-02-1131 minThe Lancet Respiratory Medicine in conversation withEosinophils in COPD: The Lancet Respiratory Medicine: September 2017Mona Bafadhel discusses her work on using eosinophils as biomarkers in chronic obstructive pulmonary disease.Continue this conversation on social!Follow us today at...https://thelancet.bsky.social/https://instagram.com/thelancetgrouphttps://facebook.com/thelancetmedicaljournalhttps://linkedIn.com/company/the-lancethttps://youtube.com/thelancettv2017-08-2605 minListen to The Lancet Respiratory MedicineEosinophils in COPD: The Lancet Respiratory Medicine: September 2017Mona Bafadhel discusses her work on using eosinophils as biomarkers in chronic obstructive pulmonary disease.2017-08-2605 min
Translational and ClinicalA deep breath inAsthma and COPD (chronic obstructive pulmonary disease) are common conditions that affect the lives of many people. Dr Mona Bafadhel studies the pathophysiology of COPD (chronic obstructive pulmonary disease). There are broadly two inflammatory phenotypes of COPD that are clinically indistinguishable but have different treatment responses. Dr Bafadhel is working on the development of novel therapeutic strategies for COPD, particularly to treat the regular periods of worsened symptoms that patients experience.2015-07-2804 minTranslational and ClinicalA deep breath inAsthma and COPD (chronic obstructive pulmonary disease) are common conditions that affect the lives of many people. Dr Mona Bafadhel studies the pathophysiology of COPD (chronic obstructive pulmonary disease). There are broadly two inflammatory phenotypes of COPD that are clinically indistinguishable but have different treatment responses. Dr Bafadhel is working on the development of novel therapeutic strategies for COPD, particularly to treat the regular periods of worsened symptoms that patients experience.2015-07-2800 minTranslational MedicineA deep breath inAsthma and COPD (chronic obstructive pulmonary disease) are common conditions that affect the lives of many people. Dr Mona Bafadhel studies the pathophysiology of COPD (chronic obstructive pulmonary disease). There are broadly two inflammatory phenotypes of COPD that are clinically indistinguishable but have different treatment responses. Dr Bafadhel is working on the development of novel therapeutic strategies for COPD, particularly to treat the regular periods of worsened symptoms that patients experience.2015-07-2804 minTranslational MedicineA deep breath inAsthma and COPD (chronic obstructive pulmonary disease) are common conditions that affect the lives of many people. Dr Mona Bafadhel studies the pathophysiology of COPD (chronic obstructive pulmonary disease). There are broadly two inflammatory phenotypes of COPD that are clinically indistinguishable but have different treatment responses. Dr Bafadhel is working on the development of novel therapeutic strategies for COPD, particularly to treat the regular periods of worsened symptoms that patients experience.2015-07-2800 minTranslational MedicineA deep breath inAsthma and COPD (chronic obstructive pulmonary disease) are common conditions that affect the lives of many people. Dr Mona Bafadhel studies the pathophysiology of COPD (chronic obstructive pulmonary disease). There are broadly two inflammatory phenotypes of COPD that are clinically indistinguishable but have different treatment responses. Dr Bafadhel is working on the development of novel therapeutic strategies for COPD, particularly to treat the regular periods of worsened symptoms that patients experience.2015-07-2804 min